Abstract: Compounds, pharmaceutical compositions, and methods of using such compounds and compositions to treat or prevent Alzheimer's disease and related tauopathies through the inhibition of USP-9X and/or enhancement of SCF(?-TrCP).
February 3, 2016
Date of Patent:
December 11, 2018
Board of Trustees of the Leland Stanford Junior University, Stanford University Office of Technology Licensing